Growing clinical studies have demonstrated that anti-PD-1 and anti-PD-L1 immunotherapy have positive responses in dMMR/MSI-H cancers but no objective responses in cold pMMR/MSS CRC [6, 7, 15]. The gene discussed is CD274; the disease is colorectal carcinoma.